Abstract
Two male patients with severe and recurrent bleeding episodes under phenprocoumon therapy are reported. Both patients exhibited a strong decrease of their factor IX activities below 1% of normal, whereas the activities of the vitamin K-dependent factors prothrombin, VII, and X were found to be within or above the expected therapeutic ranges of 20–40%. Upon removal of phenprocoumon and substitution with vitamin K, the factor IX activities increased to 85% and 55%, respectively. Reexposition to phenprocoumon in one patient confirmed the rapid and selective decrease of the factor IX activity. These findings provide the first report of an abnormally high sensitivity of factor IX activity to oral anticoagulant therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 24 October 1996 / Accepted: 13 March 1997
Rights and permissions
About this article
Cite this article
Quenzel, EM., Hertfelder, HJ. & Oldenburg, J. Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy. Ann Hematol 74, 265–268 (1997). https://doi.org/10.1007/s002770050297
Issue Date:
DOI: https://doi.org/10.1007/s002770050297